| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910409704903321 |
|
|
Titolo |
'Essentials of Cancer Genomic, Computational Approaches and Precision Medicine / / edited by Nosheen Masood, Saima Shakil Malik |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2020 |
|
|
|
|
|
|
|
ISBN |
|
|
|
|
|
|
Edizione |
[1st ed. 2020.] |
|
|
|
|
|
Descrizione fisica |
|
1 online resource (XVIII, 499 p. 59 illus., 50 illus. in color.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Cancer |
Oncology |
Medical genetics |
Bioinformatics |
Microtechnology |
Microelectromechanical systems |
Cancer Biology |
Medical Genetics |
Microsystems and MEMS |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references. |
|
|
|
|
|
|
Nota di contenuto |
|
Module 1_ Introduction -- Module 2_ Cancer Metastasis -- Module 3_ Role of Transcriptomics in cancer treatment strategies -- Module 4_Computational approaches -- Module 5_Biostatistics and clinical oncology -- Module 6_Pharmacogenomics in cancer -- Chapter 7_Case studies. |
|
|
|
|
|
|
|
|
Sommario/riassunto |
|
This book concisely describes the role of omics in precision medicine for cancer therapies. It outlines our current understanding of cancer genomics, shares insights into the process of oncogenesis, and discusses emerging technologies and clinical applications of cancer genomics in prognosis and precision-medicine treatment strategies. It then elaborates on recent advances concerning transcriptomics and translational genomics in cancer diagnosis, clinical applications, and personalized medicine in oncology. Importantly, it also explains the importance of high-performance analytics, predictive modeling, and system biology in cancer research. Lastly, the book discusses current |
|
|
|
|
|
|
|
|
|
|
and potential future applications of pharmacogenomics in clinical cancer therapy and cancer drug development. |
|
|
|
|
|
| |